1. Home
  2. TENX vs CASI Comparison

TENX vs CASI Comparison

Compare TENX & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • CASI
  • Stock Information
  • Founded
  • TENX 1967
  • CASI 1991
  • Country
  • TENX United States
  • CASI China
  • Employees
  • TENX N/A
  • CASI N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • TENX Health Care
  • CASI Health Care
  • Exchange
  • TENX Nasdaq
  • CASI Nasdaq
  • Market Cap
  • TENX 27.3M
  • CASI 24.9M
  • IPO Year
  • TENX N/A
  • CASI 1996
  • Fundamental
  • Price
  • TENX $7.34
  • CASI $1.44
  • Analyst Decision
  • TENX Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • TENX 3
  • CASI 1
  • Target Price
  • TENX $16.67
  • CASI $4.00
  • AVG Volume (30 Days)
  • TENX 96.6K
  • CASI 46.6K
  • Earning Date
  • TENX 11-14-2025
  • CASI 11-28-2025
  • Dividend Yield
  • TENX N/A
  • CASI N/A
  • EPS Growth
  • TENX N/A
  • CASI N/A
  • EPS
  • TENX N/A
  • CASI N/A
  • Revenue
  • TENX N/A
  • CASI $31,564,000.00
  • Revenue This Year
  • TENX N/A
  • CASI N/A
  • Revenue Next Year
  • TENX N/A
  • CASI N/A
  • P/E Ratio
  • TENX N/A
  • CASI N/A
  • Revenue Growth
  • TENX N/A
  • CASI 36.64
  • 52 Week Low
  • TENX $4.32
  • CASI $1.09
  • 52 Week High
  • TENX $8.24
  • CASI $6.30
  • Technical
  • Relative Strength Index (RSI)
  • TENX 54.72
  • CASI 37.46
  • Support Level
  • TENX $7.00
  • CASI $1.35
  • Resistance Level
  • TENX $7.72
  • CASI $1.73
  • Average True Range (ATR)
  • TENX 0.49
  • CASI 0.16
  • MACD
  • TENX -0.02
  • CASI -0.04
  • Stochastic Oscillator
  • TENX 75.12
  • CASI 15.45

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: